🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07130318
Recruiting Not applicable

Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise

NCT07130318 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-05-08
Last updated
2025-08-19

Condition(s) studied

Familial Mediterranean FeverNon-Alcoholic Fatty Liver Disease

Investigational drug(s) / intervention(s)

exercise plus diet restrictiondiet restriction

exercise plus diet restriction: Familial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months. also, this group, Group I, will also perform elliptical aerobic exercise (this exercise will be applied for 40 minutes three times weekly and this exercise will be maintained for 6 months)

diet restriction: Familial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months.

Study summary

Familial Mediterranean fever (FMF) affect liver and causes some dysfunctions including non-alcoholic fatty liver.. still exercise and diet limitation is the treatment for this case

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * familial Mediterrean fever women * obese women * women who have fatty live (non alcoholic type) Exclusion Criteria: * cardiac patients * respiratory disease * renal disease * cancer

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
faculty of physical therapy Cairo university Dokki Giza Governorate Recruiting

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07130318 on ClinicalTrials.gov ↗ ← All trials in Egypt